Good news!

For Simulations Plus clients, our experts are able to…

  • Leverage artificial intelligence (AI) and machine learning (ML) to assist with drug design efforts
  • Bridge physiologically based pharmacokinetic and biopharmaceutics modeling (PBPK & PBBM) with pharmacometrics
  • Provide population PK/PD analyses
  • Provide Monolix & NONMEM analyses
  • Offer expanded pharmacodynamic modeling
  • Conduct noncompartmental analysis in a validated environment with submission-ready report
  • Develop custom quantitative systems pharmacology and toxicology (QSP/QST) models to support pre-clinical/clinical drug development
  • Apply existing validated QSP & QST models in drug-induced liver damage (DILI), acute kidney injury (AKI), metabolic dysfunction-associated steatohepatitis (MASH), metabolic dysfunction-associated steatotic liver disease (MASLD), idiopathic pulmonary fibrosis (IPF), and heart failure to support regulatory interactions and internal decision making
  • Assist with data assembly, analysis, and reporting for internal decision makings and global regulatory interaction

From the point at which you begin sketching chemical structures, all the way through regulatory filings, and post-approval, Simulations Plus can help!

01. Consulting Services
All Our Consulting Services